Safety of Long-Acting Intravitreal Hydrogels: A Comprehensive Evaluation of Intraocular Pressure and Retinal Integrity across Rabbit and Non-Human Primate Models
ACS Pharmacology & Translational Science · 14.08.2026 · 9 (8) · 2105-2116
DOI: 10.1021/acsptsci.6c00243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 12.07.2026. Verfasst von Alexa K Beathard-Wojan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Oklahoma Health Campus, 1110 N Stonewall Ave, Oklahoma City, Oklahoma 73117, United States. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Pharmacy, University of Oklahoma.
Abstract (Originalsprache)
Injectable hydrogels have emerged as promising platforms for sustained drug delivery to the posterior segment of the eye, with the potential to reduce treatment burden and improve patient adherence in chronic disease management. Although numerous preclinical studies report favorable biocompatibility and biodegradability, the effects of intravitreal (IVT) hydrogels on the ocular environment have yet to be comprehensively evaluated. In this study, we conducted a meta-analysis of preclinical investigations evaluating IVT, drug-loaded hydrogels in rabbit and nonhuman primate models. Primary safety end points included longitudinal changes in intraocular pressure (IOP) and total retinal thickness (TRT). Across all included studies, no significant or sustained elevations in IOP were observed relative to baseline or untreated controls. TRT remained stable for 14 days up to two months postadministration, with no evidence of clinically meaningful thinning, degeneration, or retinal toxicity. These outcomes were consistent across diverse hydrogel compositions, therapeutic payloads, gelation mechanisms, and animal models, indicating a broadly favorable intraocular safety profile. Collectively, this analysis provides quantitative evidence supporting the ocular safety of IVT hydrogel-based drug delivery systems based on IOP and TRT measurements in preclinical models. These findings reinforce the translational potential of injectable hydrogels as biocompatible, long-acting alternatives to conventional IVT injection–based therapies and support their continued development for intraocular applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Oklahoma Health Campus, 1110 N Stonewall Ave, Oklahoma City, Oklahoma 73117, United States.
- Oklahoma School of Science and Mathematics, 1141 N Lincoln Blvd, Oklahoma City, Oklahoma 73104, United States.
ORCID-Profile: Alexa K Beathard-Wojan, Vibhuti Agrahari
Förderung
- College of Pharmacy, University of Oklahoma
Zitieren
APA
Beathard-Wojan, A. K., Boughner, B., & Agrahari, V. (2026). Safety of Long-Acting Intravitreal Hydrogels: A Comprehensive Evaluation of Intraocular Pressure and Retinal Integrity across Rabbit and Non-Human Primate Models. ACS Pharmacology & Translational Science, 9(8), 2105-2116. https://doi.org/10.1021/acsptsci.6c00243
Vancouver
Beathard-Wojan AK, Boughner B, Agrahari V. Safety of Long-Acting Intravitreal Hydrogels: A Comprehensive Evaluation of Intraocular Pressure and Retinal Integrity across Rabbit and Non-Human Primate Models. ACS Pharmacology & Translational Science. 2026;9(8):2105-2116. doi:10.1021/acsptsci.6c00243
BibTeX
@article{BeathardWojan2026,
author = {Beathard-Wojan, Alexa K and Boughner, Becci and Agrahari, Vibhuti},
title = {Safety of Long-Acting Intravitreal Hydrogels: A Comprehensive Evaluation of Intraocular Pressure and Retinal Integrity across Rabbit and Non-Human Primate Models},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {8},
pages = {2105--2116},
doi = {10.1021/acsptsci.6c00243}
}
EUVIMED